The Key To Big Pharma Deals: How Korea's ABL Reached $1bn Sanofi Agreement
Science, Data Form Backbone
ABL Bio CEO shares experience from reaching a $1bn licensing deal with Sanofi, why it chose the French giant as its partner, what happened during the negotiation process and the next steps for the Korean company.
